[Technetium citrate, new radiopharmaceutical for tumor diagnosis].
D000230:Adenocarcinoma / Q000175:diagnosis; D001859:Bone Neoplasms / Q000175:diagnosis*; D001932:Brain Neoplasms / Q000175:diagnosis*; D001943:Breast Neoplasms / Q000175:diagnosis; D002951:Citrates; D005260:Female; D006801:Humans; D008297:Male; D008579:Meningioma / Q000175:diagnosis; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000175:diagnosis; D011877:Radionuclide Imaging; D013667:Technetium
D002951:Citrates; D013667:Technetium
Technetium-Citrat als neues Radiopharmakon in der Tumordiagnostik